Response to Letter to the Editor: Fully COVID ‐19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Abstract
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Head and Neck Cancer Studies
COVID-19 and healthcare impacts
Publication details
- Journal / source
- Head & Neck
- Volume
- 48
- Issue
- 4
- Pages
- 1143–1144
- Publication date
- 30 January 2026
- Language
- EN